Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology

ClinicalTrials.gov ID: NCT01886820

Public ClinicalTrials.gov record NCT01886820. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 7:13 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To Determine the the Efficacy and Safety of \[18F\]NAV4694 PET for Detection of Cerebral β-Amyloid When Compared With Postmortem Histopathology

Study identification

NCT ID
NCT01886820
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Navidea Biopharmaceuticals
Industry
Enrollment
290 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2013 (Actual)
Primary completion
Jun 2018 (Estimated)
Completion
Sep 2018 (Estimated)
Last update posted
Jul 26, 2017

2013 – 2018

United States locations

U.S. sites
15
U.S. states
9
U.S. cities
15
Facility City State ZIP Site status
Banner Sun Health Research Institute Sun City Arizona 85351 —
University of California San Diego La Jolla California 92093 —
Neuropsychiatric Research Center of Southwest Florida Fort Myers Florida 33912 —
Mount Sinai Medical Center of Florida Miami Beach Florida 33140 —
Galiz Research Miami Springs Florida 33166 —
Compass Research Orlando Florida 32806 —
Physicians Care Clinical Research Sarasota Florida 34239 —
Rush University Medical Center Chicago Illinois 60612 —
Southern Illinois University School of Medicine Springfield Illinois 62702 —
Biomedical Research Foundation Shreveport Louisiana 71103 —
Las Vegas Radiology Las Vegas Nevada 89113 —
Albert Einstein College of Medicine The Bronx New York 10461 —
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27559 —
Wake Forest Baptist Health-Gerontology Winston-Salem North Carolina 27157 —
Valley Medical Center Centerville Ohio 45459 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01886820, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2017 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01886820 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →